{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:27:56Z","timestamp":1786728476543,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_991_17","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:37:29Z","timestamp":1529915849000},"page":"815-819","source":"Crossref","is-referenced-by-count":7,"title":["Effect of low-frequency rotary magnetic fields on advanced gastric cancer"],"prefix":"10.4103","volume":"14","author":[{"given":"Zheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changshun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230619","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rpd\/ncn270","article-title":"Exposure to electromagnetic fields and the risk of childhood leukaemia: A review","volume":"132","author":"Sch\u00fcz","year":"2008","journal-title":"Radiat Prot Dosimetry"},{"key":"R2-15-20230619","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2170\/jjphysiol.47.307","article-title":"Induction of apoptosis in human leukemic cells by magnetic fields","volume":"47","author":"Hisamitsu","year":"1997","journal-title":"Jpn J Physiol"},{"key":"R3-15-20230619","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.273.7.4035","article-title":"Stimulation of src family protein-tyrosine kinases as a proximal and mandatory step for SYK kinase-dependent phospholipase cgamma2 activation in lymphoma B cells exposed to low energy electromagnetic fields","volume":"273","author":"Dibirdik","year":"1998","journal-title":"J Biol Chem"},{"key":"R4-15-20230619","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/15368370600719067","article-title":"Effects of sinusoidal magnetic field observed on cell proliferation, ion concentration, and osmolarity in two human cancer cell lines","volume":"25","author":"Huang","year":"2006","journal-title":"Electromagn Biol Med"},{"key":"R5-15-20230619","first-page":"83","article-title":"Static and ELF magnetic fields enhance the in vivo anti-tumor efficacy of cis-platin against lewis lung carcinoma, but not of cyclophosphamide against B16 melanotic melanoma","volume":"48","author":"Tofani","year":"2003","journal-title":"Pharmacol Res"},{"key":"R6-15-20230619","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/bem.20029","article-title":"Extremely low frequency-modulated static magnetic fields to treat cancer: A pilot study on patients with advanced neoplasm to assess safety and acute toxicity","volume":"25","author":"Ronchetto","year":"2004","journal-title":"Bioelectromagnetics"},{"key":"R7-15-20230619","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/15368370903114271","article-title":"I. The little explored efficacy of magnetic fields in cancer treatment and postulation of the mechanism of action","volume":"28","author":"Elson","year":"2009","journal-title":"Electromagn Biol Med"},{"key":"R8-15-20230619","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3109\/09553000903567920","article-title":"Chronic exposure of sprague-dawley rats to 20 kHz triangular magnetic fields","volume":"86","author":"Lee","year":"2010","journal-title":"Int J Radiat Biol"},{"key":"R9-15-20230619","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/1521-186X(200012)21:8<575::AID-BEM3>3.0.CO;2-F","article-title":"In vivo enhancement of chemotherapy with static electric or magnetic fields","volume":"21","author":"Gray","year":"2000","journal-title":"Bioelectromagnetics"},{"key":"R10-15-20230619","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R11-15-20230619","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4103\/jcrt.JCRT_587_17","article-title":"Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples","volume":"13","author":"Wang","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R12-15-20230619","first-page":"477","article-title":"Target genes prediction and functional analysis of microRNAs differentially expressed in gastric cancer stem cells MKN-45","volume":"13","author":"Salehi","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R13-15-20230619","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"R14-15-20230619","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0973-1482.191631","article-title":"S-1 combined with cisplatin chemotherapy for advanced gastric cancer","volume":"12","author":"Weidong","year":"2016","journal-title":"J Cancer Res Ther"},{"key":"R15-15-20230619","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0973-1482.160050","article-title":"Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent","volume":"11","author":"Turanli","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R16-15-20230619","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"R17-15-20230619","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"key":"R18-15-20230619","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer: A systematic review and meta-analysis based on aggregate data","volume":"24","author":"Wagner","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-15-20230619","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P","article-title":"Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer","volume":"72","author":"Murad","year":"1993","journal-title":"Cancer"},{"key":"R20-15-20230619","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/bjc.1995.114","article-title":"Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer","volume":"71","author":"Pyrh\u00f6nen","year":"1995","journal-title":"Br J Cancer"},{"key":"R21-15-20230619","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3892\/ol.2012.867","article-title":"A pilot study of extremely low-frequency magnetic fields in advanced non-small cell lung cancer: Effects on survival and palliation of general symptoms","volume":"4","author":"Sun","year":"2012","journal-title":"Oncol Lett"},{"key":"R22-15-20230619","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.annonc.a058778","article-title":"Initial or delayed chemotherapy with best supportive care in advanced gastric cancer","volume":"5","author":"Glimelius","year":"1994","journal-title":"Ann Oncol"},{"key":"R23-15-20230619","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2011.36.2236","article-title":"Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A randomized, double-blind, placebo-controlled phase III study","volume":"29","author":"Ohtsu","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814040-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:35Z","timestamp":1786724855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814040-00015"}},"subtitle":["Survival and palliation of general symptoms"],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_991_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}